Research Pipeline: New Migraine Therapies in Development

You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!


Key Questions
  • What new preventatives are in development?
  • What new acute therapies are in development?
  • When can we expect a cure?
Interview Notes
Deborah Friedman

Deborah I. Friedman, MD, MPH, FAAN

Professor of Neurology & Ophthalmology
University of Texas Southwestern Medical Center

Deborah I. Friedman, MD, MPH, is a professor in the departments of neurology and ophthalmology at the UT Southwestern Medical Center. Dr. Friedman is a neuro-ophthalmologist and headache medicine specialist, the founding director of UT Southwestern’s headache and facial pain program. Dr. Friedman is board-certified in neurology by the American Board of Psychiatry and Neurology, with subspecialty certification in headache medicine by the United Council for Neurologic Subspecialties. Dr. Friedman is a fellow of the American Academy of Neurology, the American Headache Society, and the North American Neuro-Ophthalmology Society.

Unlock all 32 expert interviews with your own copy of the 2022 Migraine World Summit. Includes:

  • 32 expert interviews with seperate audio (MP3) files & transcripts
  • 26 extended, uncut interview editions
  • Lifetime access with no annual fee
Access Pass options

Related Talks for: Day 6 (2017)

Best Acute Treatments You May Not Have Tried

Lawrence C. Newman, MD

Managing Migraine Emergencies: Avoiding the ER

Richard B. Lipton, MD

Behavioural Treatments for Migraine

Paul R. Martin, PhD

Neuromodulation: New Devices That Can Ease Pain

Brian Grosberg, MD

You’re Not Alone: What People Don’t Get About Migraine

Lisa Jacobson

Leave a comment


Back to top

Loading...